-+ 0.00%
-+ 0.00%
-+ 0.00%

ZEVRA THERAPEUTICS SHARES DOWN 24.5% AFTER EU PANEL ADOPTS NEGATIVE OPINION ON CO'S RARE DISEASE DRUG APPLICATION

Reuters·07/24/2026 13:35:30

Please log in to view news